The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neutrophil-to-lymphocyte ratio as a predictor of immune checkpoint inhibitor therapy response in advanced bladder cancer.
 
Monica Nair
No Relationships to Disclose
 
Scott Dawsey
Honoraria - MJH Life Sciences
 
Nikhil Pramod
No Relationships to Disclose
 
Jean Rene Clemenceau
No Relationships to Disclose
 
Timothy D. Gilligan
No Relationships to Disclose
 
Moshe Chaim Ornstein
Consulting or Advisory Role - AVEO; Bristol Myers Squibb Foundation; Eisai; Exelixis; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Aravive (Inst); Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer
 
Christopher Eing Wee
Consulting or Advisory Role - Bayer HealthCare Pharmacuticals; Janssen
 
Amanda Nizam
Consulting or Advisory Role - AVEO
 
Nima Almassi
No Relationships to Disclose
 
Christopher J. Weight
Research Funding - Cisco Systems (Inst); Cisco Systems (Inst); Cleveland Diagnostics (Inst); Johnson and Johnson (Inst)
 
Michi Gray
No Relationships to Disclose
 
Jessica Echle
No Relationships to Disclose
 
Jay P. Ciezki
No Relationships to Disclose
 
Kevin L. Stephans
No Relationships to Disclose
 
Rahul D. Tendulkar
Honoraria - Varian Medical Systems
 
Jacob Scott
No Relationships to Disclose
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar; Nektar
Honoraria - Bristol Myers Squibb Foundation
Consulting or Advisory Role - EMD Serono; Foundation Medicine; Gilead Sciences; Guardant Health; Loxo/Lilly; Merck; Natera; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen Oncology; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Omar Y. Mian
Consulting or Advisory Role - Bayer
Research Funding - Gilead Sciences (Inst); Varian Medical Systems (Inst)
(OPTIONAL) Uncompensated Relationships - Veracyte